导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.26% | 2262/4773 |
| 近一周 | -1.11% | 333/5462 |
| 近一月 | 1.47% | 340/5421 |
| 近一季 | 1.58% | 524/5209 |
| 近半年 | -3.07% | 2115/4920 |
| 近一年 | 1.16% | 2386/4366 |
| 近两年 | 33.01% | 2158/2954 |
| 近三年 | 36.04% | 834/2253 |
| 成立以来 | 80.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.58% 1500/4961 |
-8.70% 3912/5312 |
- - |
- - |
| 2025 | 11.69% 2734/4813 |
1.16% 1686/3635 |
6.56% 441/4076 |
0.51% 3897/4524 |
3.08% 759/4813 |
| 2024 | 27.18% 199/3463 |
6.16% 308/2808 |
6.54% 149/3014 |
9.60% 2685/3129 |
2.60% 923/3463 |
| 2023 | 7.71% 135/2656 |
6.83% 640/2280 |
3.36% 98/2385 |
1.76% 278/2515 |
-4.14% 887/2655 |
| 2022 | 1.65% 31/2207 |
0.87% 108/1919 |
2.04% 1374/2016 |
-6.22% 100/2113 |
5.31% 473/2208 |
| 2021 | 14.39% 334/1822 |
4.93% 128/1255 |
-0.25% 1134/1330 |
6.34% 230/1466 |
2.78% 520/1822 |
| 2020 | -4.66% 963/1250 |
-12.29% 881/1028 |
2.52% 968/1067 |
4.95% 940/1164 |
1.03% 1045/1184 |
| 2019 | - - |
- - |
- - |
- - |
4.94% 765/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 景顺长城沪港深红利成长低波指数A VS. 长安沪深300非周期A(740101) |